$VIVS
VivoSim Labs, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is VIVS down today? It is at $0.309 (-6.24%), and our scanner flagged it 50 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VIVS spikes, and full due diligence on VIVS — key stats, earnings, dilution and insider activity. Free.
Get free $VIVS alerts the moment volume spikes
Our scanner flagged $VIVS 50 times in the last 30 days. Create a free account to track $VIVS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.309
- Change today
- -6.24%
- Previous close
- $0.330
- 52-week range
- $0.308 – $5.30
- Market cap
- $1M
- Institutional own.
- 0.95%
- Total held
- 2.8%
- Tradeable float
- 3.4M 97% of shares · after 2% insiders + 1% institutions
- Avg daily volume
- 1.5M
- Next earnings
- Aug 11 · in 4d
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.4x
- 15m
- 0.7x
- 1h
- 0.6x
- 1D
- 4.0x
Get free VIVS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $VIVS down today?
Here is the latest on VIVS from our scanner (live price and day move above). Fresh from the SEC: VivoSim Labs, INC.: VivoSim Provides Financial and Listing Compliance Update. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Insiders
0 buys, 0 sells last 3 months (5/1 over 12 months)Show 6 recent transactionsMinimize 6 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Stern Adam K Director | Acquired (grant/award) | +15K 0.4% of company | added 100% | 20K | n/a | Jan 27, 26 |
Gobel David Director | Acquired (grant/award) | +15K 0.4% of company | n/a | 15K | n/a | Jan 27, 26 |
Milhous Alison Tjosvold Director | Acquired (grant/award) | +15K 0.4% of company | added 100% | 20K | n/a | Jan 27, 26 |
Murphy Keith Officer | Acquired (grant/award) | +15K 0.4% of company | added 100% | 26K | n/a | Jan 27, 26 |
Cohen Douglas Jay Director | Acquired (grant/award) | +15K 0.4% of company | added 100% | 21K | n/a | Jan 27, 26 |
Gobel David Director | Sold (automatic/other) | -3K 0.09% of company | n/a | n/a | $7K at $2.24 | Nov 17, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $VIVS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- About $3M in size · Priced at $1.14/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$VIVS Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$VIVS Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to VIVS
Comparable names in biological products, (no diagnostic substances), closest in size first.
VIVS stock FAQ
Why is $VIVS down today?
Here is the latest on VIVS from our scanner (live price and day move above). Fresh from the SEC: VivoSim Labs, INC.: VivoSim Provides Financial and Listing Compliance Update. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the VIVS stock price today?
VIVS last traded at $0.309, down 6.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does VIVS report earnings?
VivoSim Labs, Inc. Common Stock (VIVS) is next expected to report earnings on Tuesday, August 11, 2026, about 4 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live VIVS alerts?
The VIVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VIVS 50 times in the last 30 days.
What exchange is VIVS on?
VIVS (VivoSim Labs, Inc. Common Stock) trades on XNAS, with a market cap of about $1M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is VIVS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VIVS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.